Irwin Leventhal
Urology · New York, NYNPI 1386710192
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,420 of the $2,751 with a category attached, or 88.0%. 18 manufacturers reported payments, led by Astellas Pharma US Inc at 24.2% of the total. Reporting peaked in 2019 at $771 and has fallen 69.5% since, to $235 in 2023. That places this record below the midpoint for urology clinicians in NY, where the typical reported total is $2,467.
Across 113 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$667
- Johnson & Johnson$446
- Pfizer$436
- AbbVie$189
- Urovant Sciences Inc$189
- Bayer$164
- plus $660 from 12 others
What the payments were for
- Food & beverage$2,42088%
- Education$33112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 24 | $667 |
| Johnson & Johnson | 16 | $446 |
| Pfizer | 23 | $436 |
| AbbVie(2 entities) | 9 | $189 |
| Urovant Sciences Inc | 8 | $189 |
| Bayer | 7 | $164 |
| Blue Earth Diagnostics | 5 | $153 |
| Ferring Pharmaceuticals Inc. | 5 | $130 |
| Dendreon Pharmaceuticals LLC | 3 | $96 |
| Merck | 3 | $68 |
| Zyla Life Sciences, Inc. | 3 | $66 |
| Myovant Sciences Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Clarus Therapeutics Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $21 |
| Coloplast | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,751 in reported general payments places this provider in the 50th percentile of 952 urology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 65 | $1,127 |
| Finasteride | 22 | $571 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.